David Rossi

Pesaro, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience.

Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 14, 2020

Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addicted.

Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addicted.

Journal: In vivo (Athens, Greece)

Published: April 09, 2020

What Can We Save for the First-Line Treatment of NSCLC in 2016?

What Can We Save for the First-Line Treatment of NSCLC in 2016?

Journal: World journal of oncology

Published: April 04, 2017

Secondary bone marrow malignancies after adjuvant chemotherapy for breast cancer: a report of 2 cases and a review of the literature.

Secondary bone marrow malignancies after adjuvant chemotherapy for breast cancer: a report of 2 cases and a review of the literature.

Journal: Tumori

Published: February 08, 2016

Chemoembolization in colorectal liver metastases: the rebirth.

Chemoembolization in colorectal liver metastases: the rebirth.

Journal: Anticancer research

Published: February 11, 2014

A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases.

A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: July 17, 2012

High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease.

High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease.

Journal: The oncologist

Published: May 16, 2012

Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC.

Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC.

Journal: World journal of oncology

Published: December 14, 2011

Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial.

Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial.

Journal: Targeted oncology

Published: January 29, 2010

Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.

Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.

Journal: Clinical lung cancer

Published: October 01, 2008

Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer.

Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer.

Journal: Anti-cancer drugs

Published: July 03, 2008

High safety profile and activity of oral vinorelbine in an elderly patient with metastatic breast cancer.

High safety profile and activity of oral vinorelbine in an elderly patient with metastatic breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: June 23, 2008

Showing 1-12 of 14

Last Updated: 09/26/2026